(Download video, script and still images) In medical parlance, a stroke whose origin is unknown is called "cryptogenic." It's the type of stroke that Val Stewart sustained at age 36. She describes...
Type: Upload file
Artist impression of designed mini-protein binders targeting Influenza hemagglutinin to effectively bind and neutralize the virus.
(Downloadable video soundbites and lab b-roll) Scientist David Baker discusses creating proteins custom tailored to specific therapeutic targets. See related story.
In December, the American Heart Association reported a brow-furrowing finding: 10 percent of people who take statins discontinue the drug on their own because of perceived negative side effects. One...
Research published this week in JAMA reports anew that a daily aspirin, long recommended as a preventive measure against clotting for people with heart ailments or increased risk for stroke, also...
The Institute for Protein Design will become an innovation hub for new therapeutics for a variety of common, serious diseases. It will also engineer new nanomaterials for industry. Through computer...
Strokes usually occur in people over 65, but recent headlines about Luke Perry and John Singleton show they can occur much earlier. That's something one Western Washington man knows. About halfway...